Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Scientists have found a way to see ultrafast molecular interactions inside liquids using an extreme laser technique once ...
From structure confirmation to methodology improvements, making complex natural products has driven innovation in organic ...
Seeing plastic trash while hiking inspired a Rutgers chemist to rethink why synthetic plastics last forever while natural ...
Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
Leavening agents rarely attract attention beyond the moment a cake rises or fails, yet their chemistry shapes texture, ...
Research reveals that five DNA letters can switch chromatin between fluid and solid-like states, influencing gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback